News from Innocutis A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 21, 2014, 09:17 ET
Innocutis (PRNewsFoto/Innocutis)

Innocutis Introduces Sitavig® 50mg (ACYCLOVIR) Muco-Adhesive Buccal Tablet For Relief From Herpes Labialis (Cold Sores)

 Innocutis is pleased to announce the introduction into the North American markets of Sitavig® (ACYCLOVIR) 50mg Buccal Tablet. ...

Apr 16, 2014, 08:35 ET
Dexter - The Distrophic Nail (PRNewsFoto/Innocutis Holdings, LLC)

Innocutis Introduces Dexter the Dystrophic Nail to Educate the Public on Nail Dystrophy and How Nuvail Can Help Treat This Common Problem

 Innocutis, a specialty pharmaceutical company in Dermatologic and Podiatric specialties, is pleased to announce that Nuvail...

Mar 19, 2014, 08:30 ET
Innocutis Logo.  (PRNewsFoto/Innocutis Holdings LLC)

Innocutis Holdings LLC Licenses "Sitavig" from BioAlliance Pharma

 Innocutis Holdings LLC, an innovative pharmaceutical company dedicated to marketing best-in-class branded prescription products in...

Sep 18, 2012, 08:35 ET
Bionect.  (PRNewsFoto/Innocutis)

Innocutis Announces Three New Prescribing Options for BIONECT™

Innocutis is pleased to announce the introduction of three new prescribing options of Bionect® (hyaluronic acid sodium salt, 0.2%): an...

Sep 18, 2012, 08:30 ET
Nuvail.  (PRNewsFoto/Innocutis)

Innocutis Announces the FDA Approval of Nuvail™ (Poly-Ureaurethane, 16%) for the Treatment of Nail Dystrophy

 Innocutis is pleased to announce the FDA approval of Nuvail™ (poly-ureaurethane, 16%) nail solution, a novel prescription product to...